Downgraded Variant

Dec 24, 2019

Women in one family sought preventive surgeries to head off their risk of developing cancer following genetic testing results, but the Wall Street Journal reports that their mutation was later downgraded to a variant of uncertain significance.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

Illumina Acquires French Genomic Data-Compression Startup Enancio
Phenylketonuria Genotypes Vary With Geography, Disease Severity in International Study
Canadian Consortium Launches C$2.6M Liquid Biopsy Initiative to Improve Targeted Cancer Treatment
Waters Reports Preliminary Q2 Revenue Drop of 13 to 14 Percent, Names New CEO
FDA Grants EUA to KogeneBiotech, Trax Management, and Compass Laboratory Coronavirus Tests
BioMérieux BioFire Respiratory Panel With SARS-CoV-2 Target Nabs CE Mark

Recent Headlines from
Precision Oncology News

The Scan

Cell Studies on Blood Features of Severe COVID-19 Cases, Infection-Related Phosphorylation Shifts, More

In Cell this week: proteomic and metabolomic analysis of blood from COVID-19 patients, change in phosphorylation with infection, and more.

Call to Expand

The editorial board of the Pittsburgh Post-Gazette says other lawmakers should take Florida's approach and provide additional protections against genetic discrimination.

Additional Suit

The Hill reports 17 states and the District of Columbia are suing over a new policy that would strip international students of their visas if they only attend classes online.

Racism in Public Health

Centers for Disease Control and Prevention employees call on the agency to label racism a public health crisis and examine its own policies, NPR reports.

Featured White Papers

GX Solutions – Noise Reduction

GX Solutions: The First Professional Medical-Grade Refrigerators

NGS-Based Target Capture for SARS-CoV-2 Detection and Characterization

Seeing Beyond the Limit: Detect Residual Disease and Assess Treatment Response

Jul

22

Featured Webinar

Advances in Genetic Testing for IVF Research: PGT-A, PGT-M, and Carrier Screening

Luis A. Alcaraz, cofounder of Bioarray and Journey Genomics, accredited diagnostic and research labs based in Alicante, Spain, will review how his teams use advanced genomic techniques for carrier screening research as well as for preimplantation genetic testing (PGT) in embryos for both aneuploidies (PGT-A) and monogenic disorders (PGT-M).

Jul

23

Featured Webinar

Clinical Utility of Liquid Biopsy for the Detection of T790M to Guide Lung Cancer Treatment Strategy

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.

Aug

25

Featured Webinar

Liquid Biopsy-based Molecular Risk Stratification of ALK-mutated Lung Cancer Patients

Non-small cell lung cancer (NSCLC) patients with ALK rearrangements are treated with tyrosine kinase inhibitors (TKIs), which often leads to prolonged overall survival. However, treatment resistance will almost inevitably occur, and the disease remains incurable.

Aug

27

Featured Webinar

CRISPR/Cas9 Screens to Investigate Mechanisms of Cancer Drug Resistance

Over 70 percent of breast cancers are estrogen receptor positive and are treated with endocrine therapy.

Menu